MILLGATE HEALTHCARE PARTNERSHIP — All Prescriptions & Medications — Page 13
Practice Code: P89015 | MANCHESTER, M34 2AJ
Showing results 601-650 of 792
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Rasagiline mesilate | 29 | 812 | £482 | -21.9% ▼ |
| Doxycycline monohydrate | 29 | 1,136 | £622 | +167.1% ▲ |
| Tibolone | 29 | 2,240 | £298 | -5.2% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 29 | 990 | £2.4K | +17.0% ▲ |
| Acetic acid | 29 | 190 | £178 | +150.4% ▲ |
| 29 | 310 | £123 | -32.7% ▼ | |
| 29 | 1,232 | £404 | -1.3% vs avg | |
| Glyceryl trinitrate | 28 | 840 | £1.0K | +110.7% ▲ |
| 28 | 4,780 | £84 | +11.3% ▲ | |
| 28 | 1,773 | £3.2K | -17.1% ▼ | |
| Domperidone | 27 | 4,612 | £967 | -24.3% ▼ |
| Phenobarbital | 27 | 3,469 | £1.3K | -12.2% ▼ |
| Mebendazole | 27 | 544 | £33 | +135.8% ▲ |
| Indometacin | 27 | 2,772 | £185 | +71.6% ▲ |
| 27 | 515 | £1.9K | +72.0% ▲ | |
| 27 | 135 | £278 | +129.0% ▲ | |
| Methyldopa | 26 | 2,552 | £1.4K | +52.7% ▲ |
| Losartan potassium with diuretic | 26 | 1,064 | £124 | +1.4% vs avg |
| Bempedoic acid/Ezetimibe | 26 | 924 | £1.7K | -57.4% ▼ |
| Colistimethate sodium | 26 | 1,060 | £4.6K | +130.0% ▲ |
| Levonorgestrel | 26 | 2,926 | £74 | +219.8% ▲ |
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 26 | 230.5K | £3.1K | +273.2% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 26 | 199.4K | £2.2K | +38.9% ▲ |
| Azelastine hydrochloride | 26 | 682 | £310 | +132.0% ▲ |
| 26 | 1,894 | £293 | -5.4% ▼ | |
| Prucalopride | 25 | 840 | £329 | -35.8% ▼ |
| Hyetellose | 25 | 1,040 | £461 | +210.5% ▲ |
| Imiquimod | 25 | 430 | £1.7K | +251.8% ▲ |
| Eflornithine monohydrate chloride | 25 | 1,620 | £1.5K | +255.8% ▲ |
| Hyoscine | 24 | 159 | £1.0K | +245.8% ▲ |
| Biphasic insulin lispro | 24 | 237 | £1.4K | -44.1% ▼ |
| Propylthiouracil | 24 | 1,848 | £883 | +91.0% ▲ |
| Heparinoid | 24 | 1,250 | £95 | +84.0% ▲ |
| 24 | 442 | £2.0K | -13.7% ▼ | |
| 24 | 335 | £485 | +44.2% ▲ | |
| 24 | 410 | £1.2K | -21.9% ▼ | |
| 24 | 1,200 | £3.8K | +87.9% ▲ | |
| Glycopyrronium/formoterol | 23 | 25 | £772 | -9.1% ▼ |
| Clindamycin/tretinoin | 23 | 780 | £295 | +95.9% ▲ |
| Silver sulfadiazine | 23 | 4,750 | £288 | +476.4% ▲ |
| Malathion | 23 | 4,050 | £369 | +260.1% ▲ |
| 23 | 520 | £1.6K | +114.5% ▲ | |
| Prednisolone sodium metasulphobenzoate | 22 | 41 | £13.7K | +457.0% ▲ |
| Phosphates (Rectal) | 22 | 47 | £2.1K | +80.0% ▲ |
| Hydroxyzine hydrochloride | 22 | 1,134 | £37 | -58.7% ▼ |
| Levodopa/carbidopa/entacapone | 22 | 4,228 | £2.7K | -21.3% ▼ |
| Insulin glargine/lixisenatide | 22 | 66 | £1.3K | +69.8% ▲ |
| Propiverine hydrochloride | 22 | 308 | £419 | +46.9% ▲ |
| Chlorhexidine gluconate | 22 | 7,200 | £49 | +0.2% vs avg |
| 22 | 447 | £54 | -26.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.